About Careers MedBlog Contact us

Progress of the WHO Malaria Program Risks Being Reversed by Ebola Outbreak

by Dr. Trupti Shirole on December 10, 2014 at 9:30 AM
Font : A-A+

 Progress of the WHO Malaria Program Risks Being Reversed by Ebola Outbreak

The World Health Organization (WHO) said that the progress in the malaria program risks being reversed by the Ebola outbreak. It also warned of major gaps in access to mosquito nets and anti-malaria treatments, as well as the worrying emergence of resistance to the most commonly used insecticides.

The Ebola outbreak has halted malaria programs in Sierra Leone, Guinea and Liberia putting huge strain on health services. Previously health workers were using simple tests to diagnose malaria on the spot, to better target treatments which have now been suspended in Ebola areas. Also, many people with malaria are staying away from clinics, and if they are not getting treated, the mortality will increase. WHO director-general Margaret Chan said, "The collapse of health systems has affected all core malaria interventions and is threatening to reverse recent gains."


Besides the direct consequences, the resurgence of malaria could also harm the fight against Ebola because the two have similar symptoms, making it difficult to diagnose. Another issue threatening progress on malaria worldwide is the rise of insecticide resistance, which has been reported in 49 countries since 2010, 39 of which reported resistance to two or more insecticide classes.

Last week, UNICEF launched a campaign to provide anti-malarial drugs to 2.4 million people in Sierra Leone, while global aid agency Doctors Without Borders is conducting a smaller scale effort in Liberia.

In the annual report on malaria it is noted that malaria deaths were down 47 percent between 2000 and 2013 and decreased 53 percent in children under the age of five. In sub-Saharan Africa, where 90 percent of all malaria deaths occur, the mortality rate decreased by 54 percent. 13 of the 97 malarial countries reported no cases of the disease last year, including Azerbaijan and Sri Lanka, which recorded their first ever zero result.

The death toll from malaria across Sierra Leone, Guinea and Liberia was expected to be about 20,000 a year before the outbreak. Richard Cibulskis, lead author of the malaria report, could not predict a figure now.

Source: Medindia


Recommended Reading

Latest Tropical Disease News

Oral Cholera Vaccine Launched in India by Pharma Giants
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Evolving Threat of Dengue Virus in India
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
 Watch Out for Acute Kidney Disease as a Complication of Malaria
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
India's Malaria Vaccine Gets the Green Light for First Time in Ghana
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
 Deadly Dengue Virus Hijacks Mosquito Saliva to Spread Sickness
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Progress of the WHO Malaria Program Risks Being Reversed by Ebola Outbreak Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests